FDA

201-220 of 483 results

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Wrapping Up Summer鈥檚 Health News

    President Joe Biden has signed the Inflation Reduction Act and Congress is gone until after Labor Day. But the administration and lawmakers left lots of health policy achievements behind, including new rules to facilitate the sale of over-the-counter hearing aids and a potential reorganization of the Centers for Disease Control and Prevention. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Life After 鈥楻oe鈥 Is … Confusing

    A rapidly changing landscape for abortion has left patients, providers, employers, and lawmakers alike wondering what is and is not legal and what to do next. Meanwhile, Democrats in Congress have resumed negotiations on legislation to lower drug prices and, potentially, continue expanded insurance subsidies for the Affordable Care Act. Alice Miranda Ollstein of Politico, Tami Luhby of CNN, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • A tincture bottle of CBD oil is seen on a table. A warning on the label reads, "Shake before use."

    Patients With Epilepsy Navigate Murky Unregulated CBD Industry

    The FDA has approved a cannabis-derived drug, Epidiolex, to treat some forms of epilepsy. Now people who have other forms of the condition are using over-the-counter CBD products in hopes of taming their seizures. But doctors and patients worry about the unregulated world of CBD, in which product ingredients can be a mystery.

    By Eric Berger
  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: A World Without 鈥楻oe鈥

    The Supreme Court鈥檚 decision overturning Roe v. Wade has created far more questions than it has answered about the continued legality and availability of abortion, as both abortion rights supporters and anti-abortion activists scramble to put their marks on policy. Meanwhile, Congress completes work on its gun bill and the FDA takes up the problem of the next covid-19 booster. Margot Sanger-Katz of The New York Times, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Angela Hart, who reported and wrote the latest KHN-NPR 鈥淏ill of the Month鈥 episode about two identical eye surgeries with very different price tags.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: The FDA Goes After Nicotine

    The FDA is using its power to regulate tobacco products 鈥 ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Closing In on Covid Vaccines for 鈥楾he Littles鈥

    The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • A close up photo shows a surgical face mask discarded on the ground.
    Perspective

    Will the US Overcome Its Covid Complacency Even as the Threat Returns?

    One million Americans have died from covid-19 鈥 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation鈥檚 pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.

    By Elisabeth Rosenthal
  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Taking a Shot at Gun Control

    The U.S. House passed a package of bills seeking to keep some guns out of the hands of children and teenagers, but its fate in the Senate remains a big question mark. Meanwhile, the Federal Trade Commission takes on drug and hospital prices. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Cori Uccello of the American Academy of Actuaries about the most recent report from Medicare鈥檚 trustees board.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: A(nother) Very Sad Week

    Two mass shootings in two weeks 鈥 one at a Texas elementary school that killed 19 fourth graders and two teachers 鈥 have reignited the 鈥済uns-as-public-health-problem鈥 debate. But political consensus seems as far away as ever. Meanwhile, the FDA is in the congressional hot seat over its handling of the infant formula shortage. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KHN join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Richard Baron, head of the American Board of Internal Medicine, about how doctors should discipline colleagues who spread medical misinformation.